Tomkinson NP[au] - Search Results

Year	Number of Results
1992	3
1993	1
1994	1
1996	1
2002	1
2005	1
2007	1
2008	1
2010	1
2011	1
2014	1
2015	1
2022	0

1

Components of successful lead generation.

Davis AM, Keeling DJ, Steele J, Tomkinson NP, Tinker AC. Davis AM, et al. Among authors: tomkinson np. Curr Top Med Chem. 2005;5(4):421-39. doi: 10.2174/1568026053828411. Curr Top Med Chem. 2005. PMID: 15892684 Review.

2

Designing novel building blocks is an overlooked strategy to improve compound quality.

Goldberg FW, Kettle JG, Kogej T, Perry MW, Tomkinson NP. Goldberg FW, et al. Among authors: tomkinson np. Drug Discov Today. 2015 Jan;20(1):11-7. doi: 10.1016/j.drudis.2014.09.023. Epub 2014 Oct 2. Drug Discov Today. 2015. PMID: 25281855 Review.

3

Predictivity of Simulated ADME AutoQSAR Models over Time.

Rodgers SL, Davis AM, Tomkinson NP, van de Waterbeemd H. Rodgers SL, et al. Among authors: tomkinson np. Mol Inform. 2011 Mar 14;30(2-3):256-66. doi: 10.1002/minf.201000160. Epub 2011 Mar 17. Mol Inform. 2011. PMID: 27466779

4

A rapid computational filter for predicting the rate of human renal clearance.

Paine SW, Barton P, Bird J, Denton R, Menochet K, Smith A, Tomkinson NP, Chohan KK. Paine SW, et al. Among authors: tomkinson np. J Mol Graph Model. 2010 Dec;29(4):529-37. doi: 10.1016/j.jmgm.2010.10.003. Epub 2010 Oct 20. J Mol Graph Model. 2010. PMID: 21075652

5

Identification of a putative intracellular allosteric antagonist binding-site in the CXC chemokine receptors 1 and 2.

Nicholls DJ, Tomkinson NP, Wiley KE, Brammall A, Bowers L, Grahames C, Gaw A, Meghani P, Shelton P, Wright TJ, Mallinder PR. Nicholls DJ, et al. Among authors: tomkinson np. Mol Pharmacol. 2008 Nov;74(5):1193-202. doi: 10.1124/mol.107.044610. Epub 2008 Aug 1. Mol Pharmacol. 2008. PMID: 18676678

6

P2T purinoceptor antagonists. A QSAR study of some 2-substituted ATP analogues.

Tomkinson NP, Marriott DP, Cage PA, Cox D, Davis AM, Flower DR, Gensmantel NP, Humphries RG, Ingall AH, Kindon ND. Tomkinson NP, et al. J Pharm Pharmacol. 1996 Feb;48(2):206-9. doi: 10.1111/j.2042-7158.1996.tb07124.x. J Pharm Pharmacol. 1996. PMID: 8935173

7

Reactivity patterns for redox reactions of monomer forms of myoglobin, hemocyanin and hemerythrin.

Zhang BJ, Andrew CR, Tomkinson NP, Sykes AG. Zhang BJ, et al. Among authors: tomkinson np. Biochim Biophys Acta. 1992 Sep 25;1102(2):245-52. doi: 10.1016/0005-2728(92)90106-c. Biochim Biophys Acta. 1992. PMID: 1390826

8

QSAR modeling using automatically updating correction libraries: application to a human plasma protein binding model.

Rodgers SL, Davis AM, Tomkinson NP, van de Waterbeemd H. Rodgers SL, et al. Among authors: tomkinson np. J Chem Inf Model. 2007 Nov-Dec;47(6):2401-7. doi: 10.1021/ci700197x. Epub 2007 Sep 22. J Chem Inf Model. 2007. PMID: 17887744

9

Design of potential angiogenin inhibitors.

Howlin BJ, Tomkinson NP, Chen J, Webb GA. Howlin BJ, et al. Among authors: tomkinson np. J Comput Aided Mol Des. 1994 Jun;8(3):223-30. doi: 10.1007/BF00126741. J Comput Aided Mol Des. 1994. PMID: 7964923

10

Inhibition of chymotrypsin by phenyl N-phenyl-phosphoramidochloridate.

Parkin J, Tomkinson NP, Virden R. Parkin J, et al. Among authors: tomkinson np. Biochem Soc Trans. 1992 Aug;20(3):283S. doi: 10.1042/bst020283s. Biochem Soc Trans. 1992. PMID: 1426567 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results